Malaysia - Medicaments Containing Insulin But Not Antibiotics In Measured Doses - Market Analysis, Forecast, Size, Trends And Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingPrice for Prophylactic Medicaments Containing Insulin in Malaysia - 2021
Contents:
- Price for Prophylactic Medicaments Containing Insulin in Malaysia (FOB) - 2022
- Price for Prophylactic Medicaments Containing Insulin in Malaysia (CIF) - 2022
- Exports of Prophylactic Medicaments Containing Insulin in Malaysia
- Imports of Prophylactic Medicaments Containing Insulin in Malaysia
Price for Prophylactic Medicaments Containing Insulin in Malaysia (FOB) - 2022
The average prophylactic medicaments containing insulin export price stood at $264,003 per ton in 2022, therefore, remained relatively stable against the previous year. Overall, the export price saw a noticeable increase. The pace of growth appeared the most rapid in 2019 when the average export price increased by 77%. Over the period under review, the average export prices hit record highs in 2022 and is expected to retain growth in years to come.
There were significant differences in the average prices for the major export markets. In 2022, amid the top suppliers, the country with the highest price was Singapore ($530,500 per ton), while the average price for exports to Indonesia ($34,167 per ton) was amongst the lowest.
From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Indonesia (+18.5%), while the prices for the other major destinations experienced more modest paces of growth.
Price for Prophylactic Medicaments Containing Insulin in Malaysia (CIF) - 2022
The average prophylactic medicaments containing insulin import price stood at $65,253 per ton in 2022, shrinking by -8.9% against the previous year. Overall, the import price recorded a deep contraction. The most prominent rate of growth was recorded in 2015 when the average import price increased by 43% against the previous year. As a result, import price reached the peak level of $179,174 per ton. From 2016 to 2022, the average import prices remained at a somewhat lower figure.
There were significant differences in the average prices amongst the major supplying countries. In 2022, amid the top importers, the country with the highest price was Denmark ($223,730 per ton), while the price for Brazil ($58,070 per ton) was amongst the lowest.
From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Denmark (+28.6%), while the prices for the other major suppliers experienced mixed trend patterns.
Exports of Prophylactic Medicaments Containing Insulin in Malaysia
In 2022, after three years of growth, there was significant decline in shipments abroad of medicaments containing insulin but not antibiotics in measured doses, when their volume decreased by -34.5% to 249 tons. Over the period under review, exports, however, recorded significant growth. The pace of growth was the most pronounced in 2021 when exports increased by 206% against the previous year. As a result, the exports attained the peak of 380 tons, and then dropped markedly in the following year.
In value terms, prophylactic medicaments containing insulin exports contracted notably to $66M in 2022. In general, exports, however, enjoyed a significant expansion. The most prominent rate of growth was recorded in 2020 with an increase of 235% against the previous year.
| Export of Prophylactic Medicaments Containing Insulin in Malaysia (Million USD) | |||||
|---|---|---|---|---|---|
| COUNTRY | 2019 | 2020 | 2021 | 2022 | CAGR, 2019-2022 |
| United States | N/A | 12.1 | 39.3 | 41.2 | 84.5% |
| Singapore | 3.2 | 9.3 | 29.9 | 18.1 | 78.2% |
| India | 4.0 | 5.5 | 8.4 | 3.6 | -3.5% |
| Australia | 0.6 | 0.3 | 0.6 | 0.3 | -20.6% |
| Morocco | N/A | 1.7 | 3.4 | 0.2 | -65.7% |
| Netherlands | N/A | 0.7 | 7.6 | N/A | 985.7% |
| Others | 1.5 | 1.4 | 11.1 | 2.4 | 17.0% |
| Total | 9.3 | 31.1 | 100 | 65.7 | 91.9% |
Top Export Markets for Prophylactic Medicaments Containing Insulin from Malaysia in 2022:
- United States (172.6 tons)
- Singapore (34.1 tons)
- India (31.6 tons)
- Australia (1.2 tons)
- Morocco (0.9 tons)
Imports of Prophylactic Medicaments Containing Insulin in Malaysia
Prophylactic medicaments containing insulin imports into Malaysia dropped to 74 tons in 2022, waning by -14.8% on the year before. Over the period under review, imports recorded a abrupt contraction. The growth pace was the most rapid in 2021 when imports increased by 50% against the previous year.
In value terms, prophylactic medicaments containing insulin imports shrank notably to $4.8M in 2022. In general, imports showed a deep contraction. The pace of growth appeared the most rapid in 2021 with an increase of 81% against the previous year. As a result, imports reached the peak of $6.2M, and then shrank notably in the following year.
| Import of Prophylactic Medicaments Containing Insulin in Malaysia (Thousand USD) | |||||
|---|---|---|---|---|---|
| COUNTRY | 2019 | 2020 | 2021 | 2022 | CAGR, 2019-2022 |
| Brazil | 515 | 821 | 3,874 | 3,691 | 92.8% |
| France | 1,777 | 628 | 769 | 229 | -49.5% |
| Denmark | 93.0 | 106 | 386 | 195 | 28.0% |
| India | 2,200 | 646 | 79.1 | 186 | -56.1% |
| United States | 67.1 | 359 | 266 | 135 | 26.2% |
| Italy | 536 | 385 | 293 | 59.6 | -51.9% |
| Others | 924 | 490 | 559 | 335 | -28.7% |
| Total | 6,112 | 3,434 | 6,226 | 4,830 | -7.5% |
Top Suppliers of Prophylactic Medicaments Containing Insulin to Malaysia in 2022:
- Brazil (63.6 tons)
- India (2.9 tons)
- United States (1.7 tons)
- France (1.6 tons)
- Denmark (0.9 tons)
- Italy (0.8 tons)
This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in Malaysia. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21201260 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, put up in measured doses or for retail sale
Country coverage:
- Malaysia
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Trade (exports and imports) in Malaysia
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- MARKET STRUCTURE
- TRADE BALANCE
- PER CAPITA CONSUMPTION
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS FROM 2012–2023
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS FROM 2012–2023
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
LIST OF TABLES
- Key Findings In 2023
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Per Capita Consumption In 2012-2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
- Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
- Trade Balance, In Physical Terms, 2012-2023
- Trade Balance, In Value Terms, 2012-2023
- Per Capita Consumption, 2012-2023
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2023
- Production, In Value Terms, 2012–2023
- Imports, In Physical Terms, 2012–2023
- Imports, In Value Terms, 2012–2023
- Imports, In Physical Terms, By Country, 2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, 2012–2023
- Exports, In Value Terms, 2012–2023
- Exports, In Physical Terms, By Country, 2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
281
This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in Malaysia.
395
This report provides an in-depth analysis of the market for medicaments containing corticosteroid hormones in Malaysia.
326
This report provides an in-depth analysis of the medicaments containing vitamins market in Malaysia.
315
This report provides an in-depth analysis of the market for penicillins or streptomycins medicaments in Malaysia.
443
This report provides an in-depth analysis of the global market for prophylactic medicaments containing insulin.
498
This report provides an in-depth analysis of the global market for medicaments containing corticosteroid hormones.
631
This report provides an in-depth analysis of the global medicaments containing vitamins market.
447
This report provides an in-depth analysis of the global market for penicillins or streptomycins medicaments.
281
This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in Malaysia.
395
This report provides an in-depth analysis of the market for medicaments containing corticosteroid hormones in Malaysia.
204
Discover the top import markets for medicaments containing corticosteroid hormones. Read about the import values and key statistics of the leading countries including the United States, Switzerland, China, and more.
204
Discover the top import markets for medicaments containing corticosteroid hormones. Read about the import values and key statistics of the leading countries including the United States, Switzerland, China, and more.
